JP2012528839A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012528839A5 JP2012528839A5 JP2012513673A JP2012513673A JP2012528839A5 JP 2012528839 A5 JP2012528839 A5 JP 2012528839A5 JP 2012513673 A JP2012513673 A JP 2012513673A JP 2012513673 A JP2012513673 A JP 2012513673A JP 2012528839 A5 JP2012528839 A5 JP 2012528839A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- benzyl
- oxo
- chloro
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 17
- 150000003839 salts Chemical class 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 150000002431 hydrogen Chemical class 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000002252 acyl group Chemical group 0.000 claims 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 150000002825 nitriles Chemical class 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 4
- 125000000547 substituted alkyl group Chemical group 0.000 claims 4
- 125000003107 substituted aryl group Chemical group 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 3
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- -1 2-ethyl-1-oxo-2,3-dihydro-1H-isoindol-5-yl Chemical group 0.000 claims 1
- SOQFGZCXPXINIK-UHFFFAOYSA-N 6-[(4-chlorophenyl)methylamino]-2-ethyl-3h-isoindol-1-one Chemical compound C1=C2C(=O)N(CC)CC2=CC=C1NCC1=CC=C(Cl)C=C1 SOQFGZCXPXINIK-UHFFFAOYSA-N 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- 102000004257 Potassium Channel Human genes 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 108020001213 potassium channel Proteins 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0909671.0A GB0909671D0 (en) | 2009-06-04 | 2009-06-04 | Compounds |
| GB0909671.0 | 2009-06-04 | ||
| PCT/GB2010/001092 WO2010139953A1 (en) | 2009-06-04 | 2010-06-04 | Compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012528839A JP2012528839A (ja) | 2012-11-15 |
| JP2012528839A5 true JP2012528839A5 (cg-RX-API-DMAC7.html) | 2013-07-18 |
| JP5684800B2 JP5684800B2 (ja) | 2015-03-18 |
Family
ID=40936942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012513673A Active JP5684800B2 (ja) | 2009-06-04 | 2010-06-04 | 化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8399481B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2438044B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5684800B2 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0909671D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010139953A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5740301B2 (ja) | 2008-03-27 | 2015-06-24 | パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | コラーゲン結合性合成ペプチドグリカン、調製及び使用方法 |
| GB0909672D0 (en) * | 2009-06-04 | 2009-07-22 | Xention Discovery Ltd | Compounds |
| HRP20170482T1 (hr) * | 2011-05-24 | 2017-05-19 | Symic Ip, Llc | Sintetski peptidoglikani koji vežu hijaluronsku kiselinu, dobivanje, i postupci uporabe |
| EA201591454A1 (ru) | 2013-03-15 | 2015-12-30 | Симик Биомедикал, Инк. | Связывающие внеклеточный матрикс синтетические пептидогликаны |
| WO2015164822A1 (en) | 2014-04-25 | 2015-10-29 | Purdue Research Foundation | Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction |
| WO2018010142A1 (en) * | 2016-07-14 | 2018-01-18 | Shanghai Meton Pharmaceutical Co., Ltd | Iso-citrate dehydrogenase (idh) inhibitor |
| ES2873505T3 (es) * | 2016-10-25 | 2021-11-03 | Borealis Ag | Composición de polipropileno heterofásico con propiedades ópticas y mecánicas mejoradas |
| KR20200026263A (ko) | 2017-07-07 | 2020-03-10 | 시믹 아이피, 엘엘씨 | 합성 생체접합체 |
| EP4041732A4 (en) | 2019-10-12 | 2023-10-18 | Zhejiang Meton Pharmaceutical Co., Ltd | ISOCITRATE DEHYDROGENASE INHIBITOR (IDH) |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5741819A (en) | 1995-06-07 | 1998-04-21 | 3-Dimensional Pharmaceuticals, Inc. | Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
| US6083986A (en) | 1996-07-26 | 2000-07-04 | Icagen, Inc. | Potassium channel inhibitors |
| US6077680A (en) | 1996-11-27 | 2000-06-20 | The University Of Florida | ShK toxin compositions and methods of use |
| DE19727117A1 (de) | 1997-06-26 | 1999-01-07 | Boehringer Ingelheim Pharma | Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US6194458B1 (en) | 1998-10-30 | 2001-02-27 | Merck & Co., Inc. | Benzamide potassium channel inhibitors |
| MY125533A (en) | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
| AU2003226094A1 (en) | 2002-03-27 | 2003-10-13 | Smithkline Beecham Corporation | Compounds and methods |
| TW200503994A (en) | 2003-01-24 | 2005-02-01 | Novartis Ag | Organic compounds |
| AU2004276268B2 (en) * | 2003-09-23 | 2009-01-29 | Merck Sharp & Dohme Corp. | Isoquinoline potassium channel inhibitors |
| KR100793095B1 (ko) | 2003-10-01 | 2008-01-10 | 주식회사 프로메디텍 | Ｂａｃｅ 저해효능을 가진 신규한 술폰 아미드 유도체 |
| EP1776106B1 (en) * | 2004-06-22 | 2013-08-07 | Vertex Pharmaceuticals Incorporated | Heterocyclic derivatives for modulation of calcium channels |
| US20100160304A1 (en) | 2005-01-19 | 2010-06-24 | Dainippon Sumitomo Pharma Co., Ltd | Aromatic sulfone compound as aldosterone receptor modulator |
| BRPI0615307A2 (pt) | 2005-08-25 | 2009-08-04 | Schering Corp | agonistas de adrenorreceptor alfa2c |
| US20070135435A1 (en) | 2005-11-02 | 2007-06-14 | Xiangping Qian | Certain chemical entities, compositions, and methods |
| US8110681B2 (en) * | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
| DE102006013957A1 (de) | 2006-03-27 | 2007-10-04 | Bayer Healthcare Aktiengesellschaft | Substituierte N-Benzyl-N-phenylbenzolsulfonamide |
| GB0619176D0 (en) * | 2006-09-29 | 2006-11-08 | Lectus Therapeutics Ltd | Ion channel modulators & uses thereof |
| DE102007012284A1 (de) | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| GB0710844D0 (en) | 2007-06-06 | 2007-07-18 | Lectus Therapeutics Ltd | Potassium ion channel modulators & uses thereof |
| GB0815781D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815784D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0909672D0 (en) | 2009-06-04 | 2009-07-22 | Xention Discovery Ltd | Compounds |
-
2009
- 2009-06-04 GB GBGB0909671.0A patent/GB0909671D0/en not_active Ceased
-
2010
- 2010-06-04 JP JP2012513673A patent/JP5684800B2/ja active Active
- 2010-06-04 US US12/794,493 patent/US8399481B2/en active Active
- 2010-06-04 WO PCT/GB2010/001092 patent/WO2010139953A1/en not_active Ceased
- 2010-06-04 EP EP10722754.8A patent/EP2438044B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012528839A5 (cg-RX-API-DMAC7.html) | ||
| JP5517935B2 (ja) | 細胞壊死阻害剤としてのインドール及びインダゾール化合物 | |
| JP4521428B2 (ja) | インドールスルホンアミド化合物 | |
| AR051780A1 (es) | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos | |
| RU2006137272A (ru) | Производные 2-фенилпропионовой кислоты и содержащие их фармацевтические композиции | |
| JP2008510828A5 (cg-RX-API-DMAC7.html) | ||
| JP2007524696A5 (cg-RX-API-DMAC7.html) | ||
| JP2010511013A5 (cg-RX-API-DMAC7.html) | ||
| JP2010524896A5 (cg-RX-API-DMAC7.html) | ||
| JP2006515858A5 (cg-RX-API-DMAC7.html) | ||
| JP2020521767A5 (cg-RX-API-DMAC7.html) | ||
| AR107633A1 (es) | Procedimiento para la preparación del ácido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxílico | |
| WO2001032621A1 (en) | Novel indole derivatives and drugs containing the same as the active ingredient | |
| JP4432051B2 (ja) | Ｎ−フェニル−アリールスルフォンアミド化合物、その化合物を有効成分として含有する薬剤、その化合物の合成中間体およびその製造方法 | |
| JP2010524899A5 (cg-RX-API-DMAC7.html) | ||
| AR067412A1 (es) | Moduladores de propiedades farmaceuticas de productos terapeuticos | |
| CO2020001326A2 (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
| JP2020511450A5 (cg-RX-API-DMAC7.html) | ||
| CN102924443B (zh) | 含有杂环的5-羟基吲哚类衍生物及其用途 | |
| JP2008525400A5 (cg-RX-API-DMAC7.html) | ||
| JP2009501745A5 (cg-RX-API-DMAC7.html) | ||
| JP2012528843A5 (cg-RX-API-DMAC7.html) | ||
| WO2001062708A1 (fr) | Derives d'acide benzoique, procede de production desdits derives, et medicament contenant ces derives comme principe actif | |
| RU2008118201A (ru) | Антагонист рецептора s1p3 | |
| CN106831556A (zh) | 磺酰胺类化合物及其制备方法和作为尿酸盐转运体抑制剂类药物的用途 |